Organization
University Hospital Geelong
2 abstracts
Abstract
ANALYSIS OF ABATACEPT TREATMENT RETENTION AND EFFICACY ACCORDING TO DISEASE DURATION AND TREATMENT LINE IN A REAL-WORLD SETTINGOrg: Bristol Myers Squibb, Deepscover, Biostatistics, Puteaux, France, ARC Amsterdam University Hospitals – VU University Medical & Reade, Department of Rheumatology, Amsterdam, Netherlands, Schulthess Klinik, Universitätsspital Basel, Rheumatology, Basel, Switzerland,
Abstract
ANTI-CITRULLINATED PROTEIN ANTIBODY SEROSTATUS DETERMINES 2-YEAR RETENTION OF IV AND SC ABATACEPT IN PATIENTS WITH RA IN A REAL-WORLD SETTINGOrg: Bristol Myers Squibb, ARC Amsterdam University Hospitals – VU University Medical & Reade, Department of Rheumatology, Amsterdam, Netherlands, University of Leeds, University of Manchester and The Christie NHS Foundation Trust, Evangelical Hospital, Department of Internal Medicine, Vienna, Austria,